Systemic LSD1 Inhibition Prevents Aberrant Remodeling of Metabolism in Obesity. Ramms B, Pollow DP, Zhu H, Nora C, et al. Diabetes 2022 Sep 26. pii: 147565. doi: 10.2337/db21-1131.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ramms B, Pollow DP, Zhu H, Nora C, et al. Systemic LSD1 Inhibition Prevents Aberrant Remodeling of Metabolism in Obesity. Diabetes 2022 Sep 26. pii: 147565. doi: 10.2337/db21-1131.
PMID: 36162056